130
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

The cost of liver function tests for terbinafine: an unnecessary expense

, &
Page 1789 | Received 22 Sep 2020, Accepted 15 Oct 2020, Published online: 28 Oct 2020
 

Disclosure statement

Dr. Fleischer is a consultant for Boerhringer-Ingelheim, Incyte, Qurient, SCM Lifescience and Syneos. He is an investigator for Galderma and Trevi. He has no other potential conflicts including Honoraria, Speakers bureau, Stock ownership or options, Expert testimony, Grants, Patents filed, received, pending, or in preparation, Royalties, or Donation of medical equipment. Dr. Housholder is a sub-investigator for Leo Pharma, Acetelion, and US World Meds.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.